Frontiers in Cardiovascular Medicine (Aug 2024)
Corrigendum: Selective inhibition of soluble tumor necrosis factor signaling reduces abdominal aortic aneurysm progression
- Silke Griepke,
- Emilie Grupe,
- Jes Sanddal Lindholt,
- Jes Sanddal Lindholt,
- Elizabeth Hvitfeldt Fuglsang,
- Lasse Bach Steffensen,
- Hans Christian Beck,
- Hans Christian Beck,
- Mia Dupont Larsen,
- Sissel Karoline Bang-Møller,
- Martin Overgaard,
- Martin Overgaard,
- Lars Melholt Rasmussen,
- Lars Melholt Rasmussen,
- Kate Lykke Lambertsen,
- Kate Lykke Lambertsen,
- Kate Lykke Lambertsen,
- Jane Stubbe,
- Jane Stubbe
Affiliations
- Silke Griepke
- Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark
- Emilie Grupe
- Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark
- Jes Sanddal Lindholt
- Elite Research Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Odense, Denmark
- Jes Sanddal Lindholt
- Department of Cardiothoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark
- Elizabeth Hvitfeldt Fuglsang
- Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark
- Lasse Bach Steffensen
- Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark
- Hans Christian Beck
- Elite Research Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Odense, Denmark
- Hans Christian Beck
- Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark
- Mia Dupont Larsen
- Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark
- Sissel Karoline Bang-Møller
- Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark
- Martin Overgaard
- Elite Research Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Odense, Denmark
- Martin Overgaard
- Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark
- Lars Melholt Rasmussen
- Elite Research Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Odense, Denmark
- Lars Melholt Rasmussen
- Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark
- Kate Lykke Lambertsen
- Department of Neurobiology, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark
- Kate Lykke Lambertsen
- Department of Neurology, Odense University Hospital, Odense, Denmark
- Kate Lykke Lambertsen
- BRIDGE—Brain Research—Inter-Disciplinary Guided Excellence, Department of Clinical Research, University of Southern Denmark, Odense, Denmark
- Jane Stubbe
- Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark
- Jane Stubbe
- Elite Research Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Odense, Denmark
- DOI
- https://doi.org/10.3389/fcvm.2024.1466614
- Journal volume & issue
-
Vol. 11
Abstract
No abstracts available.Keywords
- cardiovascular disease
- abdominal aortic aneurysm
- tumor necrosis factor inhibitor
- translational research
- vascular inflammation